Attorney Thomas Equels Elected to Hemispherx Biopharma Board of Directors
PHILADELPHIA, Nov. 28, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB), a Philadelphia-based biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of viral and immune-based disorders, today announced that Thomas K. Equels, President and Managing Director of the Miami-based Equels Law Firm, has been elected to its board of directors.Filed by admin at November 28th, 2008 under News